Haematological Aspects of Systemic Disease

Postgraduate Haematology: Fifth Edition

Volumn , Issue , 2007, Pages 965-978

  Mehta, Atul B ^a   Hoffbrand, A Victor ^b  

^a ROYAL FREE HOSPITAL   (United Kingdom)

^b ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

Anaemia of chronic disease; Connective tissue disorders; Endocrine disease; Haemophagocytic syndrome; Malignancy

Indexed keywords

EID: 68649085285     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470987056.ch59     Document Type: Chapter

References (18)

1. Austin JA, Shulman LN (eds) (1993) Therapy related second malignancies. Hematological Oncological Clinics North American 7: 325-499.
2. Bernard GR, Vincent JL, Laterre P et al. (2001) Efficacy and safety of recombinant human activated protein C for severe sepsis. New England Journal of Medicine, 344: 699-709.
3. Bick RL (ed.) (1992) Perplexing thrombotic and haemorrhagic disorders. Hematological Oncological Clinics North America 6: 1203-431.
4. Dallalio G, Fleury T, Neans RT (2003) Serum hepicidin in clinical specimens. British Journal of Haematology 122: 996-1000.
5. Delamore IW, Liu Yin JA (1990) Haematological Aspects of Systemic Disease. Baillière Tindall, London.
6. Ganz T (2003) Hepicidin, a key regulator of iron metabolism and mediation of anaemia of inflammation. Blood 102: 783-8.
7. Hoffbrand AV, Pettit JE (2001) Essential Haematology, 4th edn. Blackwell Science, Oxford.
8. Kurtzhals JAL, Rodrigues O, Addae M et al. (1997) Reversible suppression of bone marrow response to erythropoietin in plasmodium falciparum malaria. British Journal of Haematology, 97: 169-74.
9. Ludwig H, Rai Kr, Blade J et al. (2002) Management of disease related anaemia in patients with multiple myeloma or chronic lymphocytic leukaemia: epoietin treatment recommendations. The Haematology Journal, 3: 121-30.
10. McRae KR, Samuels P, Schreiber AD (1992) Pregnancy associated thrombocytopenia: pathogenesis and management. Blood 80: 2697-714.
11. Means RT (1999) Advances in the anaemia of chronic disease. International Journal of Haematology 70: 7-12.
12. Means RT, Krantz SB (1992) Progress in understanding the pathogenesis of anaemia of chronic disease. Blood 80: 1639-47.
13. Mehta AB, McIntyre N (1998) Haematological disorders in liver disease. Trends in Experimental and Clinical Medicine Forum 8: 8-25.
14. Nemeth E, Valore EV, Territo M et al. (2003) Hepicidin, a putative mediator of anaemia of inflammation, is a type II acute phase protein. Blood, 101: 2461-3.
15. Papadaki HA, Kritkos HD, Valatas V et al. (2002) Anaemia of chronic disease in rheumatoid arthritis is associated with increased apoptosis of bone marrow erythroid cells: improvement following anti-tumour necrosis factor-α therapy. Blood, 1001: 474-82.
16. Smith OP, White B. (1999) Infectious purpura fulmins: diagnosis and treatment. British Journal of Haematology, 104: 202-7.
17. Spivak, JL. (2002) The blood in systemic disorders. Lancet 355:1707-12.
18. The Malaria Working Party of the General Haematology Task Force of British Committee for Standards in Haematology (1997) The laboratory diagnosis of malaria. Clinical Laboratory Haematology 19: 165-70.